Bidimensional measurement of nasopharyngeal carcinoma: A simple method to predict outcomes

Clinical Otolaryngology

Volumn 34, Issue 1, 2009, Pages 26-33

  Lee, C C ^a,b,c   Ho, H C ^a   Su, Y C ^a   Lee, M S ^a   Hsiao, S H ^a   Hwang, J H ^a   Hung, S K ^a   Chou, P ^b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIDIMENSIONAL MEASUREMENT; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GENDER; GOLD STANDARD; HAZARD RATIO; HUMAN; INTRARATER RELIABILITY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RECURRENCE RISK; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TUMOR VOLUME; UNIDIMENSIONAL MEASUREMENT; UNIVARIATE ANALYSIS; VALIDITY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 60849111721     PISSN: 17494478     EISSN: 17494486     Source Type: Journal    
DOI: 10.1111/j.1749-4486.2008.01839.x     Document Type: Article

References (18)

1. Department of Health, the Executive Yuan 2004) Cancer Registry Annual Report, Republic of China, 2001. Department of Health, the Executive Yuan, Republic of China
2. Al-Sarraf M., LeBlanc M., Giri P.G. et al. (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J. Clin. Oncol. 16, 1310 1317
3. Cheng S.H., Jian J.J., Tsai S.Y. et al. (2000) Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 48, 1323 1330
4. Lee C.C., Chu S.T., Ho H.C. et al. (2008) Primary tumor volume calculation as a predictive factor of prognosis in nasopharyngeal carcinoma. Acta Otolaryngol. 128, 93 97
5. Johnson C.R., Thames H.D., Huang D.T. et al. (1995) The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography. Int. J. Radiat. Oncol. Biol. Phys. 33, 281 287
6. Willner J., Baier K., Pfreundner L. et al. (1999) Tumor volume and local control in primary radiotherapy of nasopharyngeal carcinoma. Acta Oncol. 38, 1025 1030
7. Chua D.T., Sham J.S., Kwong D.L. et al. (1997) Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int. J. Radiat. Oncol. Biol. Phys. 39, 711 719
8. World Health Organization 1979) WHO Handbook for Reporting Results of Cancer Treatment. WHO offset publication no. 48, Geneva
9. Miller A.B., Hoogstraten B., Staquet M. et al. (1981) Reporting results of cancer treatment. Cancer 47, 207 214
10. Park J.O., Lee S.I., Song S.Y. et al. (2003) Measuring response in solid tumors: comparison of RECIST and WHO response criteria. Jpn. J. Clin. Oncol. 33, 533 537
11. Watanabe H., Yamamoto S., Kunitoh H. et al. (2003) Tumor response to chemotherapy: the validity and reproducibility of RECIST guidelines in NSCLC patients. Cancer Sci. 94, 1015 1020
12. King A.D., Zee B., Yuen E.H.Y. et al. (2007) Nasopharyngeal cancers: which method should be used to measure these irregularly shaped tumors on cross-sectional imaging? Int. J. Radiat. Oncol. Biol. Phys. 69, 148 154
13. Chen M.K., Chen T.H.H., Liu J.P. et al. (2004) Better prediction of prognosis for patients with nasopharyngeal carcinoma using primary tumor volume. Cancer 100, 2160 2166
14. Sze W.M., Lee A.W.M., Yau T.K. et al. (2004) Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control. Int. J. Radiat. Oncol. Biol. Phys. 59, 21 27
15. Monetti F., Casanova S., Grasso A. et al. (2004) Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases. Lung Cancer 43, 71 74
16. Dempsey M.F., Condon B.R. Hadley D.M. (2005) Measurement of tumor "size" in recurrent malignant glioma: 1D, 2D, or 3D? AJNR Am. J. Neuroradiol. 26, 770 776
17. Teo P.M., Leung S.F., Lee W.Y. et al. (2004) Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose-tumor-control relationship above conventional tumoricidal dose. Int. J. Radiat. Oncol. Biol. Phys. 46, 445 458
18. Cheng S.H., Tsai S.Y.C., Yen K.L. et al. (2005) Prognostic significance of parapharyngeal space venous plexus and marrow involvement: potential landmarks of dissemination for stage I-III nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 61, 456 465